Solvent Selection as a Key Factor in the Performance of Semitransparent Heterojunctions Composed of Hydrogenated Nanotubes and Bismuth Sulfides.

Research on titanium nanotubes modified with metal sulfides, particularly bismuth sulfide (BiS), aims to create heterostructures that efficiently absorb sunlight and then separate photogenerated charge carriers, thereby enhancing the energy conversion efficiency. This study shows a key role of solvent used for sulfide and bismuth salt solutions used during successive ionic layer adsorption and reaction (SILAR) onto the morphology, structure, and photoresponse of the heterojunction where one element is represented by semitransparent titania nanotubes (gTiNT) and the second is BiS. Using 2-methoxyethanol and methanol during SILAR, results in remarkably photoactive 3D heterostructure and recorded photocurrents were 44 times higher compared to bare titania nanotubes.

The relationship between symptoms and regurgitant severity in primary mitral regurgitation: a cardiovascular magnetic resonance study.

In the ACC/AHA guidelines, the presence of symptoms plays a central role in determining timing surgery in primary mitral regurgitation (MR). Studies have shown a disconnect between the severity of MR and symptoms. The purpose of this study is to assess risk factors for symptoms in patients with chronic primary MR.

Male Down syndrome Ts65Dn mice have impaired bone regeneration.

Trisomy of human chromosome 21 (Ts21) individuals present with a spectrum of low bone mineral density (BMD) that predisposes this vulnerable group to skeletal injuries. To determine the bone regenerative capacity of Down syndrome (DS) mice, male and female Dp16 and Ts65Dn DS mice underwent amputation of the digit tip (the terminal phalanx (P3)). This is a well-established mammalian model of bone regeneration that restores the amputated skeletal segment and all associated soft tissues.

Spherical Manifolds Capture Drug-Induced Changes in Tumor Cell Cycle Behavior.

CDK4/6 inhibitors such as palbociclib block cell cycle progression and improve outcomes for many ER+/HER2- breast cancer patients. Unfortunately, many patients are initially resistant to the drug or develop resistance over time in part due to heterogeneity among individual tumor cells. To better understand these mechanisms of resistance, we used multiplex, single-cell imaging to profile cell cycle proteins in ER+ breast tumor cells under increasing palbociclib concentrations.